Greatland Gold more than doubles Telfer resource to 8 million ounces

Greatland Resources has delivered a major upgrade to its Telfer gold-copper project in Western Australia, with the mineral resource growing 150% to 8.0 million ounces, adding 4.8 million ounces.

The update, based on around 134,000 metres of drilling completed during 2025, also saw the higher-confidence Measured and Indicated category surge 163% to 3.8 million ounces, a critical milestone as Greatland targets an updated Ore Reserve Estimate in the June 2026 quarter.

Much of the attention has been on Greatland’s Havieron project, but today’s resource upgrade puts Telfer on par with Havieron in terms of resource.

Combined with the unchanged Havieron resource, Greatland’s total gold-copper resource base now stands at 14.9 million ounces of gold and 645,000 tonnes of copper.

The West Dome Open Pit drove much of the growth, adding 2.8 million ounces to reach 4.9 million ounces, while the Main Dome Underground more than tripled to 2.2 million ounces.

A maiden resource of 0.6 million ounces was also declared for the West Dome Underground at an average grade of 2.30g/t, roughly three times the open-pit grade, highlighting the upside of greater underground utilisation.

Greatland has more than 100,000 metres of further drilling planned for the second half of its record FY26 programme, with a substantial campaign also lined up for FY27. The company said its focus is now shifting towards higher-grade opportunities, including the West Dome Underground and the Main Dome sub-level cave area.

The resource estimate uses conservative metal price assumptions of A$4,200 per ounce for gold and A$6.50 per pound for copper, against spot prices of roughly A$6,500 and A$8.00, respectively.

Greatland Gold shares were 6% higher at the time of writing in London.

“Telfer and Havieron’s combined resource of 550Mt @ 0.84g/t Au & 0.12% Cu for 14.9Moz Au & 645Kt Cu has the potential to underpin a multi-decade, world class mining hub. Our investment in significantly increased drilling has delivered substantial organic growth, with the overall Telfer resource growing by 150% to 8.0Moz, and the higher confidence Measured and Indicated component by 163% to 3.8Moz,” said Greatland Managing Director, Shaun Day.

“The growth includes a high-grade maiden resource at the West Dome Underground project, which shows significant potential for a new mining front at Telfer and remains the focus of ongoing drilling.

“This strong resource update has been delivered by Greatland’s dedicated technical team who have executed an accelerated and extensive Telfer drilling program since taking ownership in December 2024.

“The significant growth in Measured and Indicated Resources, particularly at the West Dome Open Pit, is very pleasing with this material being of adequate geological confidence to be evaluated as part of our upcoming Ore Reserve estimate, which remains targeted for the June 2026 quarter.

“The scale of Telfer’s resource demonstrates clear potential to fully utilise our low cost 20 million tonne per annum processing infrastructure well into the future. The technical team’s focus is now to advance our higher grade opportunities including the West Dome Underground and the potential to restart Main Dome Underground’s sub-level cave, which could augment our development of Havieron.”

Afentra to spud Angola exploration well as part of organic strategy

Afentra is on the verge of spudding its first well offshore Angola after securing access to a rig under contract to state oil company Sonangol, accelerating its planned 2026 drilling programme on Block 3/05.

The AIM-listed company has signed a commercial agreement with Sonangol to use the Borr Grid jackup rig, with the Pacassa SW exploration well expected to spud within days.

It marks a meaningful step change for Afentra as it pursues an organic growth strategy, after having been focused on acquiring mature African assets rather than drilling them.

“The ability to accelerate our drilling programme is a pivotal moment for Afentra, marking a clear transition to the execution phase of our organic growth strategy,” said Paul McDade, Chief Executive Officer of Afentra.

“This opportunity is a direct result of the strong, collaborative partnership we have with Sonangol and the Joint Venture. The funding structure agreed with Sonangol allows us to fast-track the unlocking of significant potential value from both the Pacassa SW area and the Impala field without impacting our 2026 cash capex. This programme is designed to efficiently convert resources into production, growing volumes through our existing infrastructure and delivering tangible value for our shareholders. Crucially, it will also provide invaluable data to de-risk and define future prospectivity across the wider Block 3/05 area, optimising our long-term development plan.”

The two-well programme targets a potential gross production uplift of around 9,000 barrels of oil per day. Pacassa SW is an undrilled fault block adjacent to the existing Pacassa field, with up to 210 million barrels of oil in place and recoverable resources estimated at up to 70 million barrels. The second well will either be a Pacassa SW injection well or the Impala-2 development well, depending on how the first comes in.

Boohoo exceeds previous guidance with £53m EBITDA as turnaround gains pace

Boohoo group, which is rebranding around the Debenhams name, has delivered adjusted EBITDA of £53 million for the year to 28 February 2026, comfortably ahead of the £50 million it had previously guided and up 36% on the prior year.

The improvement was driven largely by the second half, where adjusted EBITDA surged 76% year-on-year, as the group’s cost-cutting programme and pivot towards a stock-lite marketplace model began to bear fruit.

CEO Dan Finley said the business had reset its cost base, completed warehouse consolidation, delivered a tech re-platform, and rightsized its stock.

Dan Finley said in a statement: “Our multi-year turnaround strategy continues at pace. We are pleased with the 76% increase in H2 Adjusted EBITDA and £53m full year Adjusted EBITDA. Our pivot to the stock-lite, capital-lite, highly profitable marketplace is working.

“The cost base has been reset, the warehouse consolidation completed, the tech re-platform delivered, the stock base rightsized, most of the onerous costs exited and the brand management teams strengthened. This is significant progress, ahead of our plan, but there is still more to be delivered and we now focus on growth.”

Fixed costs have been cut to an exit rate of £119 million, £11 million better than the £130 million guided as recently as February, and the group is targeting £100 million in FY27. All brands are trading profitably on an adjusted EBITDA basis.

Net debt stood at £90 million at the end of February, under 2x adjusted EBITDA, helped by a £40 million fundraise during the month. The board expects that ratio to fall below 1x by the end of FY27.

In terms of the outlook, the group is guiding to double-digit adjusted EBITDA growth in the year to February 2027, with capex expected to halve to around £8 million and depreciation set to fall sharply from £59 million to around £20 million as the asset base shrinks post-transformation.

“Boohoo delivered positive news to investors’ doorsteps this morning as it continues to make headway in its turnaround strategy,” said Aarin Chiekrie, equity analyst, Hargreaves Lansdown.

“In a short trading update, the fast-fashion company revealed that full-year underlying cash profits (EBITDA) are set to jump by 36% to £53mn, edging past previous guidance of £50mn, thanks to a very strong second half.”

Director deals: Adam Kaye buys Everyman shares after Omniplex stake purchase

Everyman Media Group (LON: EMAN) executive director Adam Kaye bought 500,000 shares at 25.5p each via 50% owned Kropifko Properties on 26 March. This was the same day that it was announced that Ireland-based cinema operator Omniplex has taken a 5.35% stake in cinemas operator Everyman.
Two weeks before, Adam Kaye bought 500,000 shares at 25.5p each via Kropifko Properties. His total shareholding including related interests is 9.27%.
BGF reduced its shareholding from 3.29% to 1.97%. The largest shareholding remains 29.2%, with Gresham House Asset Management holding 9.56% and Samuel Kaye 6.93%.
...

Aquis weekly movers: Connecting Excellence increases net fee income

Vault Ventures (LON: VULT) has appointed Gordon Merrylees as strategic adviser to help with UK banking deployment of post-quantum strategy. The share price gained 10.6% to 1.3p.

Executive recruiter Connecting Excellence (LON: XCE) increased net fee income by one-fifth to £890,000 in the six months to December 2025. There was cash of £1.4m and Bitcoin holdings of £2.62m (40.36 Bitcoin). Net fee income in January was £250,000. The Bitcoin holding has increased to 52.42 Bitcoin. The share price increased 10% to 1.65p.

Mendell Helium (LON: MDH) says potential acquisition M3 Helium is entering an agreement with Ritchie Exploration which will re-complete the Schneweis Ventures 13A well in Kansas. The share price improved 5.26% to 5p.

Arbuthnot Banking (LON: ARBB) reported a dip in 2025 pre-tax profit from £35.1m to £24.2m. The total underlying dividend, excluding special dividend, was raised to 53p/share. Deposits increased by 11% to £4.57bn, although lending balances fell 6% to £2.25bn. Assets under management were 21% ahead at £2.68bn. Higher interest rates should be good for the bank. Chairman and chief executive Sir Henry Angest bought 300,000 ordinary shares at 860p each. He owns 59.9% of ordinary shares and 64.9% of the non-voting shares. The share price is 3.53% higher at 880p.

EDX Medical (LON: EDX) is the primary partner in the Scottish Prostate Cancer Initiative, which is set to improve early diagnosis. Up to 25,000 men will be tested. The share price rose 2.38% to 10.75p.

Delta Gold Technologies (LON: DGQ) says that Penn State University has been promoting the quantum computing research sponsorship and technology licence agreement with the company. The share price edged up 1.14% to 44.5p.

FALLERS

The WeShop share price on Nasdaq continues to decline and reached a new low of $5.81 at the end of the week compared with a high of $200. WeCap (LON: WCAP) is a significant shareholder and its share price dipped 27.8% to 0.325p.

Hamak Strategy has taken a 3.05% stake in Vaultz Capital (LON: V3TC) and the share price declined 6.38% to 2.2p.

Sulnox Group (LON: SNOX) has gained further patents for its Eco™ Fuel Conditioners in Chile, Peru and Israel. The share price slipped 4.26% to 45p.

VSA Capital (LON: VSA) chief executive has bought 100,000 shares at 2.75p each, taking his stake to 19.8%. The share price fell 3.7% to 3.25p.

Falconedge (LON: EDGE) has appointed ZynxBTC as a strategic adviser. The share price slid 0.5% to 0.995p.

AIM movers: Burford Capital case judgement overturned

0

Share buying late in the week pushed up the share price of Jade Road Investments (LON: JADE) by 64.7% to 70 cents. There were just over 20,000 shares traded on Thursday and Friday, compared with fifteen the previous week.

Emissions reduction fuel technology developer Quadrise (LON: QED) had cash of £4m at the end of 2025 having lost £2m in the first half. The MSC vessel and OCP (Morocco) trials are being prepared and there are talks with other ship owners. The share price increased 56.7% to 2.35p.

SkinBioTherapeutics (LON: SBTX) shares initially fell following the announcement at the end of last week that interim results will be delayed but this week the share price ended up recovering 52% to 9.5p. That is back to the pre-announcement level. The board investigation is continuing. This means that trading in the shares will be suspended on 1 April. Cash was £2.44m on 19 March.

Malaysia-based mobile payments company MobilityOne (LON: MBO) says that Technology & Telecommunication Acquisition Corporation has had its prospectus approved by the SEC in the US. This brings nearer the completion of the proposed joint venture with the company. The share price rebounded 46.2% to 9.5p.  

FALLERS

Shares in spirits brands owner Distil (LON: DIS) halved to 0.045p following a trading statement outlining poor fourth quarter trading. Full year revenues will be well below expectations. Stock levels in the trade were higher than expected. Sales by the UK distributor are 51% ahead in the first two months of this year, but consumer spending remains depressed. The US launch of Blavod black vodka has been delayed due it still awaiting tax approval from the authorities. Marketing spending has been agreed with UK retailers to help sales to recover.

Litigation finance provider Burford Capital (LON: BUR) announced on Friday afternoon that the US Court of Appeals had overturned the decision won by Burford’s Petersen and Eton Park concerning claims against The Republic of Argentina and YPF. There was a two to one ruling. Argentina had not made a tender offer when it took over a 51% stake in YPF from Repsol. The $16.1bn judgement was overturned. The share price slumped 42.5% to 339p. This is the lowest the share price has been for six years.

Premier African Minerals (LON: PREM) is raising £750,000 at 0.126p/share. The previous fundraising was at 0.0185p/share. The cash will finance the installation of the new plant at the Zulu lithium and tantalum project, plus ongoing operations. The share price declined 36.9% to 0.01325p.

The Mission Group (LON: TMG) revenues fell by one-fifth to £68.8m, although continuing operations revenues were only 8% lower. Pre-tax profit on continuing operations slid 39% to £3m. The marketing services provider has net debt of £9m. Annualised cost savings will benefit this year. Onward Opportunities (LON: ONWD) has raised its stake from 10.8% to 11.1%. The share price slipped 32.4% to 12.5p.

US and UK equities, AI investing tools, and ISAs with Robinhood UK’s Dan Lane

Dan Lane, lead analyst at Robinhood UK, joins us for a wide-ranging conversation on markets, money, and the future of investing in Britain.

We open with the big macro picture, examining what the latest volatility in the Middle East means for equities and how investors should think about interest rates and inflation in an uncertain geopolitical environment.

From there, we turn to the UK investing environment. Dan gives his honest take on whether Britain has a cultural problem with investing, how younger generations are approaching the stock market differently, and what still needs to change.

We dig into ISAs and why so many people leave their annual allowance untouched, the most damaging myths Dan hears regularly, and his verdict on whether government policy will actually shift behaviour.

We finish with a look at how AI is transforming what retail investors can do today versus five years ago, and the most exciting applications Dan has seen emerging in the space.

We close on UK-listed companies. We ask whether Dan is optimistic or pessimistic right now, and if he had fresh money to put to work in one corner of the UK market today, where would it go?

FTSE 100 falls again with Brent above $110

The FTSE 100 sank on Friday after Trump’s decision to extend a deadline for strikes on Iranian power plants failed to steady markets.

London’s leading index had started the session in positive territory, but gains quickly turned to losses, leaving the FTSE 100 0.7% in the red at the time of writing.

Susannah Streeter, chief investment strategist, Wealth Club, said: “Investors are set to stay in a wary mood at the end of a week infused with nervousness about the trajectory of the war in Iran. President Trump has extended the deadline of his ultimatum to Iran, which initially offered respite from the sell-off, but a pessimistic mood has settled back in.”

The FTSE 100 is struggling to stay above 10,000 with sentiment souring and the TACO (Trump always chickens out) trade not having the same impact it had amid last year’s trade war.

Indeed, the Iranian conflict is a very different war that threatens deep repercussions for the global economy and isn’t as easy to remedy as it was to roll back on tariff threats last year. Investors will also be wary of a potential ground invasion with the US moving more troops to the region.

The oil market is having none of Trump’s claims that negotiations with Iran are progressing, and Brent Crude rose to $111 on Friday.

No one knows when the conflict will end. We do, however, know that the longer it rumbles on, the greater the risk to inflation and potential interest rate hikes that curtail economic growth. Consumer spending power is also being eroded, which will filter through to company earnings.

These risks were front and centre on Friday as 90% of the FTSE 100’s constituents traded in the red.

It was a familiar story on Friday, with cyclical and interest-rate-sensitive sectors leading the way lower.

Miners fell as Antofagasta erased all of this year’s gains with another 3% decline. The copper miner has lost around a third of its value since the Middle East war began.

There was more pain for housebuilders. Barratt Redrow fell 2.6% and is now down 31% since the start of 2026. Barratt is the worst-performing FTSE 100 stock of the year. Almost all of this year’s losses were suffered since the US and Israel launched attacks on Iran.

Metlen Energy & Metals was the FTSE 100’s top faller, down 6%, after the group delayed the release of its FY2025 results by nine days.

“In London, the big faller was Metlen Energy & Metals. The Greek company is enduring a bumpy start to life on the London market, having shifted its listing last summer,” said AJ Bell investment director Russ Mould.

“Guidance was cut in February and delaying results is never a good look.”

AstraZeneca was the FTSE 100’s top riser on the back of positive trial results for a chronic obstructive pulmonary disease (COPD) treatment.

AIM movers: Stakebuilding in Everyman Media and Switch Metals MRE delayed

1

Ireland-based cinema operator Omniplex has taken a 5.35% stake in Everyman Media Group (LON: EMAN). The share price rebounded 13.7% to 29p.

ImmuPharma (LON: IMM) has received a first Combined Search and Examination Report for the UK patent for autoimmune disease programme P140. A supporting study has been completed. The company recently raised £6.5m at 6p/share. ImmuPharma says that there is significant interest from potential licence partners for P140. The share price improved 10.3% to 5.015p.

Rockrose Energy has bought more shares in bid target Deltic Energy (LON: DELT). It acquired 529,000 shares at 3.4822p each, taking the shareholding in the oil and gas company to 3.19%. The recommended offer is 7.46p/share. The share price rose 7.14% to 3.75p.

Hargreaves Services (LON: HSP) has launched a tender offer at 850p/share. Originally, the indicative price was 750p and the amount being spent has been raised from £15m to £20m. Further renewable assets have been sold since the original announcement. The share price increased 7.14% to 785p.

FALLERS

Switch Metals (LON: SWT) has announced the washing programme has been completed for the Issia tantalum and lithium in the Côte d’Ivoire. Laboratory assays and modelling is ongoing so that the maiden mineral resource estimate can be published. This had been expected in the first quarter of 2026. The share price dived 24.1% to 11p.

Interim figures for Parkmead Group (LON: PMG) had £12.9m in cash at the end of 2025 and since then the cash position has grown to £16.1m. This will provide funding for oil and gas and renewable asset investment. Up to £120m more can become payable for the past sale of UK North Sea assets depending on the approval of field developments. The share price slipped 8.33% to 22p.

Computer vision technology Seeing Machines (LON: SEE) says that it expects to be EBITDA positive in the third and fourth quarters of the financial year to June 2026. Interim revenues dipped from $25.3m to $23.4m, due to planned reductions in non-core operations. Automotive royalties and aftermarket revenues both increased and gross margin improved to 58%. There will be a refinancing by June. The share price declined 4.84% to 2.95p.

Coiled Therapeutics (LON: COIL), which was formerly Roquefort Therapeutics, has moved from the Main Market to AIM acquiring the global rights to a potential cancer treatment known as AO-252. This cost £31.9m in shares. AO-252 is “a brain-penetrant small molecule targeting Transforming Acidic Coiled-Coil Containing protein 3 (TACC3) protein-protein interactions”. Preclinical trials have indicated the effectiveness in tumour regression in some cancers. A placing is raised £8.5m at 10p/share. valuing the company at £42.6m. The share price initially fell 5% but recovered to 10p.  

Inside Polar Capital Technology Trust’s AI maximalist investment strategy  

Polar Capital Technology Trust (PCT) has been one of the standout performers in the technology investment trust space over the past year.  

For the trust’s financial year to date, its Net Asset Value (NAV) total return of 72% and share price return of 77% has outperformed its benchmark, the Dow Jones Global Technology Index, which has returned 40% over the same period (as at 27 February 2026, all figures in Sterling terms. The Company’s financial year ends on the final day of April each year).  

If there were ever an investment trust to demonstrate the benefits of active management over passive investment, Polar Capital Technology Trust could well be it.  

The managers pursue a high-conviction, high-turnover approach to investing in the AI revolution, and its lead manager, Ben Rogoff, describes it as “an active, active manager.” 

The thesis: discontinuous progress 

At the heart of PCT’s strategy is the view that AI is not following the normal arc of technological adoption. Rather than advancing incrementally, AI is exhibiting what Rogoff calls “discontinuous progress,” where decades of development compress into years.  

The trust draws parallels with the printing press, railway construction, and mass production.  These are moments where technology didn’t just improve people’s lives, but fundamentally rewired how economies function. 

This framing matters because it shapes how PCT allocates capital. Where a conventional technology fund manager might wait for clear evidence of mainstream adoption before committing, PCT’s team is incredibly forward-thinking and prepared to spend time exploring areas that others may overlook. We look at what this means in practise later in this article.  

Exploding enterprise revenues, enormous capital expenditure commitments, and rapid AI model improvement are all cited by the PCT team as confirmation that the inflection point has arrived.  

In their view, 2026 is the year AI transitions from a topic of debate to a key driver of economic performance. 

Gauging growth: revenue, capex, and adoption 

PCT tracks several key indicators to validate its thesis. The most striking is the revenue trajectory of the leading AI model providers. OpenAI’s annualised recurring revenue grew from roughly $10 billion to over $20 billion in less than twelve months through to the end of 2025, and had reportedly reached $25 billion by early March 2026. Anthropic’s growth has been even more dramatic on a relative basis, growing from $1 billion in annualised revenue in late 2024 to $9 billion by the end of 2025, before accelerating to $14 billion by mid-February 2026 and $19 billion by early March. 

Capital expenditure from the hyperscalers Alphabet, Amazon, Meta, and Microsoft, provides a second critical signal. Consensus estimates now project combined hyperscaler capex of $667 billion in 2026, around 62% higher than the prior year and $127 billion above where expectations stood at the start of Q4 earnings season. Google alone guided to $180 billion at the mid-point, considerably above the $130 billion the market had expected. Amazon raised its outlook to $200 billion, spanning AI, chips, robotics, and low earth orbit satellites. 

The adoption of AI tools worldwide reinforces the thesis. OpenAI confirmed 900 million weekly active users and 50 million paying consumer subscribers. Alphabet processes well over a quadrillion tokens monthly across its AI services, a figure that has grown several times over in under a year. PCT’s manager argues these metrics point to a structural shift in how businesses and consumers interact with technology. Importantly, the demand curve is steepening, not flattening. 

Portfolio Construction: Hardware Over Software 

PCT’s portfolio construction reflects a core belief that the AI cycle is fundamentally a hardware story, not a software one. Their view was validated in early 2026, when software stocks were ravaged by fears of AI disruption, sector by sector. Some of the world’s leading SaaS names have lost well over 50% of their value in recent years. 

But PCT appears to have been ahead of the game, and the trust has dramatically reduced its software exposure, increasing its allocation to semiconductors, power infrastructure, optical networking, and memory. These are the physical building blocks of AI, sometimes known as the ‘AI enablers’. 

Semiconductors and semiconductor equipment represent the largest sector allocation at roughly 37% of the portfolio, followed by interactive media and services, and technology hardware. Software, by contrast, has been cut to less than 5%, a negligible weighting, driven by the team’s conviction that agentic AI, combined with outcome-oriented pricing, will disrupt traditional headcount-based software-as-a-service models. 

Geographically, the trust has been shifting away from the US at the margin, with Asia Pacific exposure growing. The US and Canada still account for around 64% of the portfolio, but the trust holds meaningful positions in Asian names like TSMC and Samsung Electronics, reflecting the concentration of advanced semiconductor manufacturing in the region. 

Perhaps the most telling feature of the portfolio is its active share, which sits near recent highs at around 49%. The trust holds approximately 94–98 positions but makes large individual-stock bets and is willing to have zero weightings in major index constituents when the growth case doesn’t stack up. The manager is significantly underweight the “Magnificent Seven” group of mega-cap US technology companies and is content to use call options to manage the upside risk of being underweight names like Apple, Microsoft, and Alphabet. 

Current holdings: Following the bottlenecks 

PCT’s top ten holdings read as a map of the AI supply chain. NVIDIA remains the largest position at around 9–10% of NAV, though the trust is notably underweight relative to the benchmark. Alphabet has risen sharply in the portfolio following the success of its Gemini 3 model and the commercialisation of its custom TPU chips. TSMC, Broadcom, and Samsung Electronics round out the semiconductor-heavy upper echelons of the portfolio. 

The more interesting story, however, lies in the relatively under-the-radar overweight positions. These may be the positions that distinguish PCT from a passive technology vehicles. LAM Research, a memory chip equipment manufacturer benefiting from acute DRAM and NAND supply bottlenecks, was the trust’s largest overweight at the end of 2025.  

Ciena and Lumentum Holdings, both optical networking specialists, represent high-conviction positions driven by the manager’s belief that power-intensive electrical networking is increasingly threatened by fibre-optic alternatives. Ciena’s shares have risen over 300% in the past year. Lumentum’s have risen over 850%. These companies’ returns would have had a negligible impact on the majority of passive alternatives.  

Even more unconventionally, PCT took a position in Caterpillar on the basis that its industrial generators provide a near-term solution to the power squeeze constraining data centre expansion, and that its mining equipment exposure gives it leverage to rising copper demand. 

Ben Rogoff has explained in a recent video interview that PCT is always looking for the most important companies in the AI story. This may not always be the ‘Mag 7’ companies responsible for the capex driving the industry forward.  

The risks and the conviction 

PCT’s manager is clear-eyed about the risks. If AI model progress stalls, investment momentum could reverse quickly. But this risk is considered small enough not to materially detract from the investment case.  

Geopolitical uncertainty, including tensions in the Middle East and shifts in US trade policy, adds further complexity. The trust’s concentrated sector focus means that a broad downturn in technology sentiment would hit hard. 

Yet the trust continues to invest with a high level of conviction and doesn’t buy into the idea of an ‘AI bubble’. Most of the performance in the technology sector in recent years has been driven by earnings growth rather than valuation expansion, a crucial distinction from the late 1990s bubble.  

AI spending currently represents around 1% of global GDP. Historical precedent suggests this could rise to 2–5% at peak intensity over a cycle lasting five to ten years. Should this come to pass, the companies in the PCT portfolio will be direct beneficiaries.  

For those that share PCT’s view on the continued expansion of AI, the recent bout of volatility in equity markets has presented an interesting opportunity in a widening of the discount to NAV around 9.2%. 

Past performance is not indicative or a guarantee of future returns.